表紙
市場調査レポート

CountryFocus:インドネシアの医療・規制・医療費償還制度の情勢

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia

発行 GlobalData 商品コード 299161
出版日 ページ情報 英文 178 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
CountryFocus:インドネシアの医療・規制・医療費償還制度の情勢 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Indonesia
出版日: 2016年02月01日 ページ情報: 英文 178 Pages
概要

当レポートでは、インドネシアの医療・規制・医療費償還制度について調査分析し、医薬品・医療機器市場の概要、医療費償還制度とその関連情報、規制当局の構造や規制の概要、国の情勢、医療インフラなどの最新情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
  • 医療機器市場
  • 市場促進要因・障壁

第4章 市場参入

  • 医療費償還・保険料払込者の情勢
  • 規制情勢

第5章 国の分析

  • 政策環境
  • 経済情勢
  • 経済指標
  • 人口統計
  • 医療インフラ
  • 医療費
  • 産業団体
  • 見本市

第6章 機会と課題

  • 機会
  • 課題

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0058CHR

The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in US. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

The population of Indonesia in 2014 was approximately 252 million, having grown at a CAGR of 1.7% from 2008. The country's increasingly elderly population and a corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was worth $2.99 billion in 2008 and is projected to reach approximately $6.24 billion by 2014 at a Compound Annual Growth Rate (CAGR) of 12.4%. The overall market is estimated to reach $ 12.6 billion by 2020. New health insurance scheme Jaminan Kesehatan Nasional (JKN) - Universal Health Coverage (UHC) aims to provide health insurance to 250 million people by 2019. The Indonesia medical device market was valued at $793m in 2013 and is projected to grow at a CAGR of 4.9% to an estimated $872m billion in 2020.

These growth trends can be primarily attributed to -

  • Improved access to healthcare facilities
  • Increase in healthcare insurance coverage

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Indonesia, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Kalbe Farma, Tempo Scan Pacific, Kimia Farma, Darya Varia Laboratories and Indofarma and market overview of medical device market.
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Indonesia's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Indonesia's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Indonesia's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Supply Channels
    • 3.1.3. Market Segments
    • 3.1.4. Major Drug Classes
    • 3.1.5. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Reimbursement and Payer Landscape
    • 4.1.1. Overview of Healthcare System
    • 4.1.2. Reimbursement Process
    • 4.1.3. Overview of Insurance Providers
    • 4.1.4. Patient Share of Healthcare Expenditure
    • 4.1.5. Healthcare Price Trends
    • 4.1.6. Pricing Policies
  • 4.2. Regulatory Landscape
    • 4.2.1. Overview of Regulatory Agencies
    • 4.2.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.2.3. New Medical Device Approval Process
    • 4.2.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.2.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.2.6. Intellectual Property Rights
    • 4.2.7. Clinical Trial Regulations
    • 4.2.8. Pharmaceutical Advertising Regulations
    • 4.2.9. Pharmacy Regulations
    • 4.2.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. Government Structural Balance
    • 5.3.9. Government Gross Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.2. Healthcare Parameters
    • 5.5.3. Environmental Health
    • 5.5.4. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview of Healthcare Expenditure
    • 5.6.2. Major Components of Healthcare Expenditure
    • 5.6.3. Healthcare Expenditure Distribution
  • 5.7. Trade Associations
    • 5.7.1. International Pharmaceutical Manufacturers Group
    • 5.7.2. Indonesia Pharmaceutical Association
    • 5.7.3. Indonesia Medical Association
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2015
  • Table 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015-2020
  • Table 3: Pharmaceutical Market, Indonesia, Distribution Channel Price Margins (%), 2014
  • Table 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014
  • Table 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2014
  • Table 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2014
  • Table 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005
  • Table 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005
  • Table 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005
  • Table 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005
  • Table 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segment (%), 2005
  • Table 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005
  • Table 13: Major Products, PT Kalbe Farma, Revenue, 2014
  • Table 14: Major Products, PT Tempo Scan Pacific, 2014
  • Table 15: Major Products, PT Darya-Varia Laboratoria, 2014
  • Table 16: Major Products, PT Indofarma, 2014
  • Table 17: Medical devices, Imports market size ($m), 2013
  • Table 18: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011
  • Table 19: Overview of Insurance Providers, Indonesia, Public Health Insurance Schemes Overview, 2010
  • Table 20: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008-2014
  • Table 21: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2014
  • Table 22: Regulatory Landscape, Indonesia, New Drug Registration Categories, 2014
  • Table 23: Regulatory Landscape, Indonesia, Patent Application Fees, 2014
  • Table 24: Impact of Natural Calamities, Indonesia, 1996-2009
  • Table 25: Economic Indicators, Indonesia, GDP per Capita ($), 2008-2015
  • Table 26: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016-2020
  • Table 27: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2015
  • Table 28: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016-2020
  • Table 29: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2014
  • Table 30: Economic Indicators, Indonesia, CPI, 2008-2015
  • Table 31: Economic Indicators, Indonesia, Consumer Price Index, Forecast, 2016-2020
  • Table 32: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008-2015
  • Table 33: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016-2020
  • Table 34: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2014
  • Table 35: Economic Indicators, Indonesia, FDI ($bn), 2008-2014
  • Table 36: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2014
  • Table 37: Economic Indicators, Indonesia, Trade balance ($bn), 2008-2014
  • Table 38: Economic Indicators, Indonesia, Imports ($bn), 2008-2014
  • Table 39: Economic Indicators, Indonesia, Exports ($bn), 2008-2014
  • Table 40: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008-2014
  • Table 41: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008-2014
  • Table 42: Economic Indicators, Indonesia, Major industries by GDP share (%), 2014
  • Table 43: Demographics, Indonesia, Population (million), 2008-2015
  • Table 44: Demographics, Indonesia, Population (million), Forecast, 2016-2020
  • Table 45: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2015
  • Table 46: Demographics, Indonesia, Urban and Rural Population Share (%), 2016-2020
  • Table 47: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2015
  • Table 48: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016-2020
  • Table 49: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2014
  • Table 50: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2014
  • Table 51: Demographics, Indonesia, Causes of Mortality ('000), 2012
  • Table 52: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008-2014
  • Table 53: Demographics, Indonesia, Immunization Rate (%), 2008-2014
  • Table 54: Demographics, Indonesia, Gender Ratio (M/F), 2008-2014
  • Table 55: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2015
  • Table 56: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016-2020
  • Table 57: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2014
  • Table 58: Demographics, Indonesia, School Enrollment by Age Group (%), 2014
  • Table 59: Demographics, Indonesia, Unemployment (%), 2008-2014
  • Table 60: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010
  • Table 61: Demographics, Indonesia, DALY (Per 100,000 Population), 2004
  • Table 62: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2014
  • Table 63: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008-2014
  • Table 64: Healthcare Infrastructure, Indonesia, Hospitals by Type of Care, 2014
  • Table 65: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008-2014
  • Table 66: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008-2014
  • Table 67: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2014
  • Table 68: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2014
  • Table 69: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008-2014
  • Table 70: Environmental Health, Indonesia, Access to Protected Drinking Water (%), 2013
  • Table 71: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008
  • Table 72: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2014
  • Table 73: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008-2014
  • Table 74: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008-2014
  • Table 75: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008-2014
  • Table 76: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008
  • Table 77: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008-2014
  • Table 78: Trade Fairs, Indonesia, Major Healthcare Trade Fairs, 2013-2014

List of Figures

  • Figure 1: Pharmaceutical Market, Indonesia, Revenue ($bn), 2008-2015
  • Figure 2: Pharmaceutical Market, Indonesia, Revenue Forecast ($bn), 2015-2020
  • Figure 3: Pharmaceutical Market, Indonesia, Distribution Chain, 2014
  • Figure 4: Pharmaceutical Market, Indonesia, Pharmaceutical Distribution (%), 2014
  • Figure 5: Pharmaceutical Market, Indonesia, OTC, Revenue ($bn), 2008-2014
  • Figure 6: Pharmaceutical Market, Indonesia, Pharmaceutical Market Share (%), 2008-2014
  • Figure 7: Pharmaceutical Market, Indonesia, Major Therapeutic Areas (%), 2005
  • Figure 8: Pharmaceutical Market, Indonesia, Antibiotics Market Segments (%), 2005
  • Figure 9: Pharmaceutical Market, Indonesia, Respiratory Drug Market Segments (%), 2005
  • Figure 10: Pharmaceutical Market, Indonesia, Neuromuscular Drug Market Segments (%), 2005
  • Figure 11: Pharmaceutical Market, Indonesia, Vitamins and Minerals Market Segments (%), 2005
  • Figure 12: Pharmaceutical Market, Indonesia, Dermatological Drug Market Segments (%), 2005
  • Figure 13:Medical Device , Imports market size, 2013
  • Figure 14: Healthcare Market, Indonesia, Drivers and Barriers, 2014
  • Figure 15: Market Access, Indonesia, History of Health Insurance System, 1968-2014
  • Figure 16: Market Access, Indonesia, Process for Addition to Hospital Drug Formulary, 2014
  • Figure 17: Overview of Insurance Providers, Indonesia, Health Insurance Coverage (%), 2011
  • Figure 18: Overview of Insurance Providers, Indonesia, Share of OOP Patient Healthcare Expenditure (%), 2008-2014
  • Figure 19: Overview of Insurance Providers, Indonesia, Healthcare Inflation (%), 2008-2014
  • Figure 20: Regulatory Landscape, Indonesia, Structure of the National Agency of Drug and Food Control, 2014
  • Figure 21: Regulatory Landscape, Indonesia, New Drug Market Authorization Process, 2014
  • Figure 22: Regulatory Landscape, Indonesia, Generic Drug Market Authorization Process, 2014
  • Figure 23: Regulatory Landscape, Indonesia, Medical Device Approval Process, Indonesia, 2014
  • Figure 24: Regulatory Landscape, Indonesia, Licensing Process for Manufacturing, 2014
  • Figure 25: Regulatory Landscape, Indonesia, Structure of the Directorate General of Intellectual Property Office, 2014
  • Figure 26: Regulatory Landscape, Indonesia, Patent Approval Process, 2014
  • Figure 27: Regulatory Landscape, Indonesia, Clinical Trial Regulation Process, 2014
  • Figure 28: Economic Indicators, Indonesia, GDP Per Capita ($), 2008-2015
  • Figure 29: Economic Indicators, Indonesia, GDP per Capita ($), Forecast, 2016-2020
  • Figure 30: Economic Indicators, Indonesia, GDP Annual Growth (%), 2008-2015
  • Figure 31: Economic Indicators, Indonesia, GDP Annual Growth (%), Forecast, 2016-2020
  • Figure 32: Economic Indicators, Indonesia, GNI per Capita ($), 2008-2014
  • Figure 33: Economic Indicators, Indonesia, CPI, 2008-2015
  • Figure 34: Economic Indicators, Indonesia, CPI, Forecast, 2016-2020
  • Figure 35: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2008-2015
  • Figure 36: Economic Indicators, Indonesia, Average Annual Consumer Price Change (%), 2016-2020
  • Figure 37: Economic Indicators, Indonesia, Currency Exchange Rate (IDR/$), 2008-2014
  • Figure 38: Economic Indicators, Indonesia, FDI ($bn), 2008-2014
  • Figure 39: Economic Indicators, Indonesia, Foreign Exchange Reserves ($bn), 2008-2014
  • Figure 40: Economic Indicators, Indonesia, Trade Balance ($bn), 2008-2014
  • Figure 41: Economic Indicators, Indonesia, Imports ($bn), 2008-2014
  • Figure 42: Economic Indicators, Indonesia, Exports ($bn), 2008-2014
  • Figure 43: Economic Indicators, Indonesia, Government Structural Balance ($bn), 2008-2014
  • Figure 44: Economic Indicators, Indonesia, Government Gross Debt ($bn), 2008-2014
  • Figure 45: Economic Indicators, Indonesia, Major Industries by GDP Share (%), 2014
  • Figure 46: Demographics, Indonesia, Population (million), 2008-2015
  • Figure 47: Demographics, Indonesia, Population (million), Forecast, 2016-2020
  • Figure 48: Demographics, Indonesia, Urban and Rural Population Share (%), 2008-2015
  • Figure 49: Demographics, Indonesia, Urban and Rural Population Share (%), 2016-2020
  • Figure 50: Demographics, Indonesia, Population Distribution by Age Group (%), 2008-2015
  • Figure 51: Demographics, Indonesia, Population Distribution by Age Group (%), Forecast, 2016-2020
  • Figure 52: Demographics, Indonesia, Births (Per 1,000 Population), 2008-2014
  • Figure 53: Demographics, Indonesia, Mortality (Per 1,000 Population), 2008-2014
  • Figure 54: Demographics, Indonesia, Causes of Mortality ('000), 2012
  • Figure 55: Demographics, Indonesia, Children under Five, Mortality (Per 1,000 Live Births), 2008-2014
  • Figure 56: Demographics, Indonesia, Immunization Rate (%), 2008-2014
  • Figure 57: Demographics, Indonesia, Gender Ratio (M/F), 2008-2014
  • Figure 58: Demographics, Indonesia, Life Expectancy at Birth (Years), 2008-2015
  • Figure 59: Demographics, Indonesia, Life Expectancy at Birth (Years), 2016-2020
  • Figure 60: Demographics, Indonesia, Illiteracy by Age Group (%), 2008-2014
  • Figure 61: Demographics, Indonesia, School Enrollment by Age Group (%), 2014
  • Figure 62: Demographics, Indonesia, Unemployment (%), 2008-2014
  • Figure 63: Demographics, Indonesia, Causes of Hospitalization by Hospital Inpatients (Per 100,000 Population), 2010
  • Figure 64: Demographics, Indonesia, DALYs (Per 100,000 Population), 2004
  • Figure 65: Healthcare Infrastructure, Indonesia, Public and Private Hospitals, 2008-2014
  • Figure 66: Healthcare Infrastructure, Indonesia, Health Centers (per 30,000 Population), 2008-2014
  • Figure 67: Healthcare Infrastructure, Indonesia, Number of Hospitals by Type of Care, 2014
  • Figure 68: Healthcare Infrastructure, Indonesia, General Hospital Beds (per 100,000 Population), 2008-2014
  • Figure 69: Healthcare Infrastructure, Indonesia, Beds (Per 1,000 Population), 2008-2014
  • Figure 70: Healthcare Infrastructure, Indonesia, Physicians (Per 100,000 Population), 2008-2014
  • Figure 71: Environmental Health, Indonesia, CO2 Emissions (Million Metric Tons), 2008-2014
  • Figure 72: Environmental Health, Indonesia, PM10 Emissions (µg/m3), 2008-2014
  • Figure 73: Environmental Health, Indonesia, Access to Protected Drinking Water, 2013
  • Figure 74: Environmental Health, Indonesia, Share of Waste by Handling Method (%), 2008
  • Figure 75: Healthcare Personnel, Indonesia, Nurses (Per 100,000 Population), 2008-2014
  • Figure 76: Healthcare Personnel, Indonesia, Pharmacists (Per 100,000 Population), 2008-2014
  • Figure 77: Healthcare Personnel, Indonesia, Dentists (Per 100,000 Population), 2008-2013
  • Figure 78: Healthcare Expenditure, Indonesia, Healthcare Expenditure (% of GDP), 2008-2014
  • Figure 79: Healthcare Expenditure, Indonesia, Share of Major Components (%), 2008
  • Figure 80: Healthcare Expenditure, Indonesia, Public-Private Share of Healthcare Expenditure (%), 2008-2014
  • Figure 81: Healthcare Market, Indonesia, Opportunities and Challenges, 2014
Back to Top